The "Drugs for Rheumatoid Arthritis: Global Markets to 2022" report has been added to Research And Markets' offering.

This research report categorizes the drugs for rheumatoid arthritis market by type. Product type include disease modifying anti-rheumatic drugs, non-steroidal anti-inflammatory drugs and corticosteroids.

Report Includes:

• 95 data tables
• An overview of the global rheumatoid arthritis drugs market
• Analyses of global market trends, with data from 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2022
• Identification of segments with high growth potential and their future applications
• Explanation of major drivers and regional dynamics of the market and current trends within the industry

Key Topics Covered:

1 Introduction

2 Summary and Highlights

3 Drugs for Rheumatoid Arthritis Market Characteristics

4 Drugs for Rheumatoid Arthritis Market Size and Growth

• Historic Market Growth
• Drivers of the Market
• Restraints on the Market
• Forecast Market Growth
• Drivers of the Market
• Restraints on the Market

5 Drugs for Rheumatoid Arthritis Market Trends and Strategies

• Increasing Use of Technology
• 3D Printing Technologies
• Combo and Mono Therapy
• New Applications of NSAIDS

6 PESTLE Analysis

• Political
• Government Financial Support
• Uncertain Political Policies
• Economic
• Wealth
• Globalization
• Emerging Markets
• Social
• Ageing Global Population
• Sedentary Lifestyles
• Health Consciousness and Awareness
• Traditional Medicine Continues to Pose Threat to Market
• Technological
• 3D Printing Technologies
• Internet Penetration and Mobile Applications
• Legal
• Stringent Regulations and Long Approval Procedures
• Investment Regulations
• Patent Issues
• Government Intervention
• Environmental

7 Drugs for Rheumatoid Arthritis Market Segmentation

• Global Drugs for Rheumatoid Arthritis Market, By Segment
• Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Segment, 2013-2022
• Disease Modifying Anti-Rheumatic Drugs (DMARDs)
• Market Characteristics
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
• Market Characteristics
• Corticosteroids
• Market Characteristics

8 Drugs for Rheumatoid Arthritis Market Regional and Country Analysis

• Global Drugs for Rheumatoid Arthritis Market, By Region
• Global Drugs for Rheumatoid Arthritis Market, 2013-2022, Historic and Forecast, By Region
• Global Drugs for Rheumatoid Arthritis Market Segmentation, By Region, 2017
• Global Drugs for Rheumatoid Arthritis Market, By Country
• Global Drugs for Rheumatoid Arthritis Market, Historic and Forecast, By Country
• Global Drugs for Rheumatoid Arthritis Market Segmentation, 2017, By Country

9 Global Drugs for Rheumatoid Arthritis Market Comparison with Macro Economic Factors

• Global Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure
• Per Capita Average Drugs for Rheumatoid Arthritis Market Expenditure, By Country

10 Asia-Pacific Drugs for Rheumatoid Arthritis Market

11 Asia-Pacific Drugs for Rheumatoid Arthritis Market: Country Analysis

12 Western Europe Drugs for Rheumatoid Arthritis Market

13 Western Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

14 Eastern Europe Drugs for Rheumatoid Arthritis Market

15 Eastern Europe Drugs for Rheumatoid Arthritis Market: Country Analysis

16 North America Drugs for Rheumatoid Arthritis Market

17 North America Drugs for Rheumatoid Arthritis Market: Country Analysis18 South America Drugs for Rheumatoid Arthritis Market

19 South America Drugs for Rheumatoid Arthritis Market: Country Analysis

20 Middle East Drugs for Rheumatoid Arthritis Market

21 Africa Drugs for Rheumatoid Arthritis Market

22 Drugs for Rheumatoid Arthritis Market Customer Information

• Frequency of Pain after Treatment
• Different Symptoms Experienced by Patients
• Impact of Rheumatoid Arthritis at Workplace
• Importance of Patient's Role in the Management of Rheumatoid Arthritis
• Capacity of Affordable Treatment

23 Drugs for Rheumatoid Arthritis Market Competitive Landscape

• Company Profiles
• Abbvie Inc.
• Amgen Inc.
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche AG
• Pfizer

24 Key Mergers and Acquisitions in the Drugs for Rheumatoid Arthritis Market

• Pfizer Acquired Hospira
• Concordia Healthcare Acquired Covis Pharma Commercial Assets
• Bristol-Myers Squibb Acquired Padlock Therapeutics
• Alvotech Acquired Baliopharm
• Atnahs Acquired Pharmaceutical Assets of F. Hoffmann-La Roche

25 Appendix

Companies Mentioned

• AbbVie Inc.
• Amgen Inc.
• Biogen
• Merck & Co.
• Bristol-Myers Squibb
• Hoffmann-La Roche
• Johnson & Johnson
• Mitsubishi Tanabe Pharma Corporation
• Pfizer
• UCB S.A.

Register as Visitor to CPhI China 2018!